Laurion Capital Management LP - WEREWOLF THERAPEUTICS INC ownership

WEREWOLF THERAPEUTICS INC's ticker is HOWL and the CUSIP is 95075A107. A total of 46 filers reported holding WEREWOLF THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 1.0%.

Quarter-by-quarter ownership
Laurion Capital Management LP ownership history of WEREWOLF THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,119,006
-29.8%
522,9000.0%0.01%
-22.2%
Q2 2023$1,594,845
+17.3%
522,9000.0%0.01%0.0%
Q1 2023$1,359,540
+26.8%
522,9000.0%0.01%
+80.0%
Q4 2022$1,071,945
-54.5%
522,9000.0%0.01%
-64.3%
Q3 2022$2,358,000
+7.7%
522,900
-2.3%
0.01%
-58.8%
Q2 2022$2,189,000535,1600.03%
Other shareholders
WEREWOLF THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
DC Funds, LP 589,102$10,274,00048.81%
MPM ASSET MANAGEMENT LLC 4,284,172$74,716,00013.89%
MPM BioImpact LLC 2,388,011$41,647,0006.84%
Soleus Capital Management, L.P. 563,396$9,826,0001.51%
RA Capital Management 4,291,881$74,850,0001.20%
SPHERA FUNDS MANAGEMENT LTD. 706,294$12,049,0000.82%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,552,787$44,521,0000.79%
Nicholas Investment Partners, LP 294,654$5,139,0000.32%
Avidity Partners Management LP 650,265$11,341,0000.31%
PFM Health Sciences, LP 400,000$6,976,0000.22%
View complete list of WEREWOLF THERAPEUTICS INC shareholders